Therapy Areas
26 April 2019 - Precigen Inc, a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) is opening a new manufacturing facility, it was reported yesterday.The company started construction of the facility in 2018 to support gene therapy manufact...
26 April 2019 - Kite, a Gilead Company (Nasdaq: GILD), announced yesterday that it is planning for a new facility in Frederick County, Maryland.The facility is to produce innovative cell therapies for cancer patients. It is intended to expand the com...
26 April 2019 - Arrhythmia care company Acutus Medical revealed on Thursday that it has obtained CE mark approval in Europe for its AcQMap contact mapping software.The new software offers expanded functionality which provides physicians with more opt...
26 April 2019 - Biotherapeutics company CSL Behring reported on Thursday the receipt of US Food and Drug Administration (FDA) approval in 4- and 5-gram vial sizes for ZEMAIRA [Alpha1-Proteinase Inhibitor (Human)]therapy for treating Alpha 1 Antitryps...
26 April 2019 - - US-based clinical stage biotechnology company Cavion, Inc will present the results of the Phase 2 study of its lead compound, CX-8998, for essential tremor in a platform presentation during the American Academy of Neurology 71st ann...
26 April 2019 - - US-based Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has begun dosing in a new triple combination cohort (cohort 12) that includes JNJ-3989 (formerly ARO-HBV) and additional undisclosed agents selected by Janssen Pharmaceuticals, ...
25 April 2019 - - The US Food and Drug Administration has granted Orphan Drug Designation to dexpramipexole, US-based drug discovery and development company Knopp Biosciences LLC's oral drug candidate for the treatment of hypereosinophilic syndr...